Back to Search Start Over

Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis: values) or 2-way ANOVA with Bonferroni post hoc test (for >2 groups). A P value less than 0.05 was considered significant

Authors :
Nie, Lei
Guo, Xiaojia
Esmailzadeh, Leila
Zhang, Jiasheng
Asadi, Abolfazl
Collinge, Mark
Li, Xuan
Kim, Jun-Dae
Woolls, Melissa
Jin, Suk-Won
Dubrac, Alexandre
Eichmann, Anne
Simons, Michael
Bender, Jeffrey R.
Sadeghi, Mehran M.
Source :
Journal of Clinical Investigation. December 1, 2013, Vol. 123 Issue 12, p5082, 16 p.
Publication Year :
2013

Abstract

Introduction Angiogenesis is a tightly regulated process during development and growth, and wound healing in adult organisms. Dysregulated angiogenesis, whether inadequate or exaggerated, con-tributes to a wide variety of pathologies, [...]<br />Aberrant blood vessel formation contributes to a wide variety of pathologies, and factors that regulate angiogenesis are attractive therapeutic targets. Endothelial and smooth muscle cell-derived neuropilin-like protein (ESDN) is a neuropilin-related transmembrane protein expressed in ECs; however, its potential effect on VEGF responses remains undefined. Here, we generated global and EC-specific Esdn knockout mice and demonstrated that ESDN promotes VEGF-induced human and murine EC proliferation and migration. Deletion of Esdn in the mouse interfered with adult and developmental angiogenesis, and knockdown of the Esdn homolog (dcbld2) in zebrafish impaired normal vascular development. Loss of ESDN in ECs blunted VEGF responses in vivo and attenuated VEGF-induced VEGFR-2 signaling without altering VEGF receptor or neuropilin expression. Finally, we found that ESDN associates with VEGFR-2 and regulates its complex formation with negative regulators of VEGF signaling, protein tyrosine phosphatases PTP1B and TC-PTP, and VE-cadherin. These findings establish ESDN as a regulator of VEGF responses in ECs that acts through a mechanism distinct from neuropilins. As such, ESDN may serve as a therapeutic target for angiogenesis regulation.

Details

Language :
English
ISSN :
00219738
Volume :
123
Issue :
12
Database :
Gale General OneFile
Journal :
Journal of Clinical Investigation
Publication Type :
Academic Journal
Accession number :
edsgcl.356455009